Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 10/20 | 0.59 |
| ▸ | RARA | P10276 | 2/20 | 0.59 |
| ▸ | RARG | P13631 | 1/20 | 0.59 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MTOR | P42345 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.42 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16258119 | 1.00 | RARB (0.59) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL16258012 | 1.00 | RARB (0.59) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL9329602 | 0.98 | RARB (0.57) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL16258015 | 0.95 | RARB (0.66) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL16258029 | 0.95 | RARB (0.66) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL16258039 | 0.95 | RARB (0.66) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL11035363 | 0.93 | RARB (0.68) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL8375678 | 0.93 | RARB (0.64) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL16258040 | 0.92 | RARB (0.52) | RARBRARARARGCYP17A1CYP11B1 | |
| SCHEMBL16258030 | 0.92 | RARB (0.52) | RARBRARARARGCYP17A1CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160024383-A1 | LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME | DIC CORPORATION (JP) | 2016-01-28 | — | — | US | disclosed |
| US-20160024383-A1 | LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME | DIC CORPORATION (JP) | 2016-01-28 | — | — | US | disclosed |
| EP-2806011-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC Corporation (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-8211820-B2 | Catalyst composition, and process for production of cross-coupling compound using the same | KYOTO UNIVERSITY (JP) | 2012-07-03 | — | — | US | disclosed |
| US-20100094018-A1 | CATALYST COMPOSITION, AND PROCESS FOR PRODUCTION OF CROSS-COUPLING COMPOUND USING THE SAME | KYOTO UNIVERSITY (JP) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094018-A1 | CATALYST COMPOSITION, AND PROCESS FOR PRODUCTION OF CROSS-COUPLING COMPOUND USING THE SAME | F11, PYM1, CA2 | RARB 3864/4885RARA 3998/4885RARG 4296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.